Literature DB >> 8105814

Early neuroleptic intervention in schizophrenia: are prodromal symptoms valid predictors of relapse?

W Gaebel1, U Frick, W Köpcke, M Linden, P Müller, F Müller-Spahn, A Pietzcker, J Tegeler.   

Abstract

All recently completed controlled two-year studies on intermittent, early neuroleptic intervention treatment have failed to compare favourably with studies on maintenance treatment concerning relapse prevention. The reason for this failure is still unclear. Therefore the implicit, but as yet unproven, hypothesis that a relapse can be predicted from prodromal symptoms was tested from the perspective of our German multicentre study. Results demonstrate that this is not the case. Possible reasons for and clinical implications of this negative finding are discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8105814

Source DB:  PubMed          Journal:  Br J Psychiatry Suppl        ISSN: 0960-5371


  9 in total

1.  Ethical concerns in schizophrenia research: looking back and moving forward.

Authors:  Scott T Wilson; Barbara Stanley
Journal:  Schizophr Bull       Date:  2005-11-10       Impact factor: 9.306

Review 2.  Review: treatment of schizophrenia. State of the art.

Authors:  H J Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

Review 3.  Antipsychotic medication for early episode schizophrenia.

Authors:  John Bola; Dennis Kao; Haluk Soydan
Journal:  Cochrane Database Syst Rev       Date:  2011-06-15

4.  How are we doing? A statewide survey of community adjustment among people with serious mental illness receiving intensive outpatient services.

Authors:  W F Dailey; M J Chinman; L Davidson; L Garner; E Vavrousek-Jakuba; S Essock; K Marcus; J K Tebes
Journal:  Community Ment Health J       Date:  2000-08

Review 5.  Depot antipsychotic drugs. Place in therapy.

Authors:  J M Davis; L Matalon; M D Watanabe; L Blake; L ] Metalon L [corrected to Matalon
Journal:  Drugs       Date:  1994-05       Impact factor: 9.546

6.  Trajectories and changes in individual items of positive and negative syndrome scale among schizophrenia patients prior to impending relapse.

Authors:  Dai Wang; Srihari Gopal; Susan Baker; Vaibhav A Narayan
Journal:  NPJ Schizophr       Date:  2018-06-20

7.  Feasibility of using a smartphone app to assess early signs, basic symptoms and psychotic symptoms over six months: A preliminary report.

Authors:  Emily Eisner; Sandra Bucci; Natalie Berry; Richard Emsley; Christine Barrowclough; Richard James Drake
Journal:  Schizophr Res       Date:  2019-04-09       Impact factor: 4.939

8.  E-Prevention: Advanced Support System for Monitoring and Relapse Prevention in Patients with Psychotic Disorders Analyzing Long-Term Multimodal Data from Wearables and Video Captures.

Authors:  Athanasia Zlatintsi; Panagiotis P Filntisis; Christos Garoufis; Niki Efthymiou; Petros Maragos; Andreas Menychtas; Ilias Maglogiannis; Panayiotis Tsanakas; Thomas Sounapoglou; Emmanouil Kalisperakis; Thomas Karantinos; Marina Lazaridi; Vasiliki Garyfalli; Asimakis Mantas; Leonidas Mantonakis; Nikolaos Smyrnis
Journal:  Sensors (Basel)       Date:  2022-10-05       Impact factor: 3.847

Review 9.  The nature of relapse in schizophrenia.

Authors:  Robin Emsley; Bonginkosi Chiliza; Laila Asmal; Brian H Harvey
Journal:  BMC Psychiatry       Date:  2013-02-08       Impact factor: 3.630

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.